Similar to NNMT overexpression, MNA-treated hepatocytes show a dose-dependent increase in glucose production, Sirt1 protein expression, G6pc mRNA expression, and Pck1 mRNA expression compared to controls and these changes caused by MNA treatment can be abolished by Sirt1 knockdown [14]
Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, et al
These values are estimates only
Widely Referenced in Research Settings
Major US clinical guidelines for diabetes and obesity management do not include recommendations for lipotropic injections
This can be particularly beneficial for individuals with weakened immune systems, such as those undergoing cancer treatment, dealing with chronic infections, or recovering from illness